The European Medicines Agency (EMA) has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer ...

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

In this article, we will take a look at the 12 stocks that will double in 2025.

As such, the tech giant is conducting a limited test of ads on Threads with a small number of advertisers, allowing them to extend their existing Meta ad campaigns to the app while the service ...

Levi Garraway, Roche’s chief medical officer and head of global product development, said: “The INAVO120 overall survival ...

Sanofi’s Sarclisa (isatuximab) has been approved by the Medicines and Healthcare product Regulatory Agency (MHRA) as part of a combination treatment for newly diagnosed multiple myeloma (MM).

Hastings and Andreas Wicki, PhD Retire from Board of Directors -- PARSIPPANY, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Pacira ...

International investigators have arrested 418 suspects as part of an operation targeting the trade of fake medicines and illicit substances in 30 countries, the European Union's law enforcement body ...